Subscribe to MDT Magazine News

FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium

March 14, 2011 2:36 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., March. 14, 2011 /- Life Technologies Corporation (Nasdaq: LIFE ) today announced it has received FDA 510(k) clearance for StemPro® MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a...


LaVoie Group Wins Two Mercury Excellence Awards

March 14, 2011 2:36 am | by Bio-Medicine.Org | Comments

SALEM, Mass., March 14, 2011 /- LaVoie Group, the acknowledged leader in life science and pharmaceutical communications, announced today that it has received a Gold Award in the 24th Annual International Mercury Excellence Awards 2010/2011 competition, given annually by MerComm, Inc....


Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology

March 14, 2011 12:32 am | by Bio-Medicine.Org | Comments

BLUE BELL, Pa., March 14, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB (formerly Tripep AB), has initiated a Phase...


Santarus Stockholders Get Their Share of Disappointing News

March 13, 2011 11:35 pm | by San Diego Business Journal | Comments

Santarus Inc. stockholders weren't exactly hopping for joy after the U.S. Food and Drug Administration declined approval Feb. 26 of a product based on a new treatment for hereditary angioedema, or swelling of the face and airways, derived from rabbit's milk.


Opportunity for Expansion Rises in Far East for Life Sciences Company

March 13, 2011 11:34 pm | by San Diego Business Journal | Comments

Life Technologies Corp. has joined a growing group of local biotech firms continuing to invest in Asia. The Carlsbad company announced that it has opened a 62,300-square-foot distribution center


Taking tamoxifen to prevent breast cancer can save lives and money

March 13, 2011 9:33 pm | by EurekAlert | Comments

(Wiley-Blackwell) Tamoxifen, taken by certain women as a preventive measure against breast cancer, saves lives and reduces medical costs. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results...


Tolerx, GSK diabetes drug candidate misses goal

March 13, 2011 8:37 pm | by Mass High Tech: The Journal of New England Technology | Comments

A Phase 3 clinical study of a type 1 diabetes treatment by Cambridge biotech Tolerx Inc., in conjunction with British pharmaceutical giant GlaxoSmithKline, failed to meet its primary endpoint.

Department of Energy announces funding to support the next generation of American scientists and engineers

March 13, 2011 8:37 pm | by I-Micronews | Comments

Fellowship programs to support innovative research and ensure U.S. leadership in clean energy.


A New Approach to Treating Rheumatoid Arthritis

March 13, 2011 8:36 pm | by Massachusetts Institute of Technology | Comments

An engineered protein reduces arthritis symptoms in mice.

Miniature 'wearable' PET scanner ready for use

March 13, 2011 11:33 am | by EurekAlert | Comments

(DOE/Brookhaven National Laboratory) Scientists have demonstrated the efficacy of a "wearable," portable PET scanner they've developed for rats. The device will give neuroscientists a new tool for simultaneously studying brain function and behavior in fully awake, moving animals.


Covidien Receives FDA Approval for South African-Produced Medical Isotope Based on Low-Enriched Uranium

March 11, 2011 4:34 pm | by Covidien | Comments

ST. LOUIS, Mar 10, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the use of molybdenum-99 (Mo-99) derived from low-enriched uranium (LEU) in the production of...


Edwards Lifesciences buys Embrella Cardiovascular

March 11, 2011 1:45 pm | by The Associated Press | Comments

Heart valve maker Edwards Lifesciences Corp. said Friday that it has completed the purchase of Embrella Cardiovascular Inc. for $43 million in cash.Embrella developed a single-use disposable deflector system that can be used during heart procedures without blocking blood flow to the brain. The...

Class I, II Devicemakers Must Continue Malfunction Reports

March 11, 2011 1:31 pm | by U.S. Food & Drug Administration | Comments

Manufacturers and importers of all devices must continue to submit malfunction reports as they await a promised easing of requirements for Class I devices and Class II devices that are not permanently implantable, life supporting or life sustaining.


Senate Clears Patent Reform Bill in Victory for Devicemakers

March 11, 2011 1:31 pm | by U.S. Food & Drug Administration | Comments

Device manufacturers have won a victory in Congress now that the Senate has passed patent-reform legislation that includes several provisions favorable to the industry.


Halozyme 4Q loss widens on revenue dip

March 11, 2011 12:45 pm | by The Associated Press | Comments

Biotechnology company Halozyme Therapeutics Inc. on Friday reported a wider fourth-quarter loss due to lower revenue and higher costs.The developer of enzyme-focused products, said it lost $16.9 million, or 17 cents per share, in the last three months of 2010, compared with a loss of $12.7...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.